Cytomegalovirus Retinitis Market Segment and Forecast Up to 2023,Research Reports -Transparency Market Research

Cytomegalovirus Retinitis Market - Global

Industry Analysis, Size, Share, Growth, Trends, Single User

and Forecast 2015 - 2023

USD 4315.5









Transparency Market Research

State Tower,

90, State Street, Suite 700.

Albany, NY 12207

United States

www.transparencymarketresearch.com

sales@transparencymarketresearch.com

License:

Flat 10% Discount!!

Free Customization as per your requirement

You will get Custom Report at Syndicated Report

price

Report will be delivered with in 15-20 working days

Request Sample

Buy Now

REPORT DESCRIPTION

Cytomegalovirus (CMV) Retinitis is caused by cytomegalovirus infection, which is a herpes-type virus that affects the retina of the human eye

among patients having a weak immune system that could be due to conditions such as AIDS, leukemia and/or pregnancy. Symptomatic conditions

include floaters, flashes, and blind spots besides loss of peripheral or blurred vision in the eyes of immune compromised patients.CMV infection

often leads to hemorrhagic retinal inflammation along with vascular distribution. The CMV infection if left untreated spreads from one eye to the

other, eventually leading to visual loss and/or complete blindness. Therefore, prompt diagnosis through blood as well as urine tests besides other

optical tests that involve withdrawal of a small specimen fluid from the infected eye is recommended.

Browse Full Report With TOC:- http://www.transparencymarketresearch.com/cytomegalovirus-retinitis-market.html

Global CMV retinitis market can be segmented on the basis of anti-CMV drugs or anti-infective ophthalmic drugs into Foscarnet, Ganciclovir,

Cidofovir, Fomivirsen and others. In the anti-CMV drugs segment, various off-label drugs are also being used, however many of these drugs have

serious contraindications. In this market segment, one of the key challenges is drug resistance which needs to be counterfeited with clinical trials

and pipeline drugs. For instance, intraocular...